Medicine with Active Substance Cerliponaze Alfa Tender - 142711163

Procurement Summary

Country: Slovakia

Summary: Medicine with Active Substance Cerliponaze Alfa 150 Mg, Infusion Solution Description: the Subject of the Order is Medicine with Active Substance Cerliponase Alfa 150 Mg, Infusion Solution Pharmaceutical Form: Sol Inf 5 Ml/150 Mg+5...

Deadline: 10 Jul 2026

Posting Date: 05 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 142711163

Document Ref. No.: 7789 - MST

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: EUR 2678664.6

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

MEDICINE WITH ACTIVE SUBSTANCE CERLIPONAZE ALFA 150 MG, INFUSION SOLUTION Description: The subject of the order is Medicine with active substance cerliponase alfa 150 mg, infusion solution Pharmaceutical form: sol inf 5 ml/150 mg+5 ml prepl. solution (drug.inj.skl.) Administration: intracerebroventricular use The drug cerliponase alfa belongs to a group of drugs known as enzyme replacement therapy. It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. People with with CLN2 disease, they do not have an enzyme called TPP1 or they have too little of it, which causes the accumulation of substances called lysosomal accumulation substances. In people with CLN2 disease, these substances accumulate in some parts of the body, especially in the brain. This medicine replaces the defective an enzyme called TPPA, thereby minimizing the accumulation of lysosomal storage substances. This medicine works by slowing down the progress of the disease. The recommended dose is 300 mg of cerliponase alfa administered once every two weeks intracerebroventricular infusion. Estimated need for the mentioned medicine for 24 months is 360 MJ (180 packs of 2x5ml/150mg+1x5ml prepl. solution or equivalent). By describing the subject of the contract in detail, the public procurer has set the minimum requirements that he wants to comply with for the given subject contracts. In the event that the public procurer used a specific manufacturer, production process, brand, patent, type, country, region or place of origin or production in the description of the subject of the contract, the applicant may, in accordance with § 42 par. 9 of the Public Procurement Act submit an offer also for a technical and functional equivalent. Order type: Goods 4.1.3 Procurement scope Estimated value Estimated value (BT-27-Procedure) (value): 2, 678, 664.6 Estimated value (BT-27-Procedure) (currency): Euro Maximum value framework agreement Max...
Deadline for submission of bids: (date): 10.07.2026 Deadline for submission of bids (time): 08:30 Binding of the bid Deadline for when the bid must remain binding Deadline for when the bid must remain binding (BT-98-Lot) (value): 4 Deadline for when the bid must remain binding (BT-98-Lot) (unit): Month Language of bids Language of bids Language in which bids can be submitted: Slovak Language of bids Language in which bids can be submitted: čestina Information on opening of bids Date of opening of bids: 10.07.2026 Bid opening time: 09:30 Bid opening place: electronically Method of submitting bids or requests to participate Electronic bid submission: Mandatory Bid submission address (URL): https://www.isepvo.sk Information on tender documents Information on competition materials Competition materials in official languages ​​Competition materials in official language Competition materials in official language Official language of competition materials: Slovak Restricted access to competition materials: No restrictions on access to by document Competition documents (URL): https://www.uvo.gov.sk/vyhladavanie/vyhladavanie-zakaziek/dokumenty/558938 Designation of document/contract: Competition documents Communication channel ad hoc Name of electronic means: IS EVO Review Deadlines for review Description deadline for review: Deadlines for submitting objections are governed by the valid and effective law on public procurement. Review Organization ID of the organization responsible for the review: ORG-0001 (Public Procurement Office) Organization providing information on reviews ID of the provider of information about the review: ORG-0001 (Public Procurement Office) Profile of the Purchaser Order: DRUG WITH ACTIVE SUBSTANCE CERLIPONAZA ALFA 150 MG, INFUSION SOLUTION ...

Documents

 Tender Notice